Longitudinal Monitoring of the Development of Antifilarial Antibodies and Acquisition of Wuchereria bancrofti in a Highly Endemic Area of Haiti

PLoS Neglected Tropical Diseases

Volumn 6, Issue 12, 2012, Pages

  Hamlin, Katy L ^a   Moss, Delynn M ^a   Priest, Jeffrey W ^a   Roberts, Jacquelin ^a   Kubofcik, Joseph ^b   Gass, Katherine ^c   Streit, Thomas G ^d   Nutman, Thomas B ^b   Eberhard, Mark L ^a   Lammie, Patrick J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Task Force for Global Health   (United States)

^d UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLCARBAMAZINE; MEBENDAZOLE; MEMBRANE PROTEIN; PARASITE ANTIBODY; PARASITE ANTIGEN;

AGE; ARTICLE; BRUGIA MALAYI; CHILD; DISEASE TRANSMISSION; DNA LIBRARY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; FOLLOW UP; HAITI; HOOKWORM INFECTION; HUMAN; IMMUNOPRECIPITATION; INFANT; LONGITUDINAL STUDY; LYMPHATIC FILARIASIS; MALE; MICROFILARIASIS; PRESCHOOL CHILD; PREVALENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SEROLOGY; WUCHERERIA BANCROFTI;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CHILD; CHILD, PRESCHOOL; ELEPHANTIASIS, FILARIAL; ENDEMIC DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGIC METHODS; FEMALE; HAITI; HUMANS; INFANT; LONGITUDINAL STUDIES; MALE; MICROSCOPY; PARASITEMIA; TIME FACTORS; WUCHERERIA BANCROFTI;

EID: 84872032300     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001941     Document Type: Article

References (34)

1. Lammie PJ, Reiss MD, Dimock KA, Streit TG, Roberts JM, et al. (1998) Longitudinal analysis of the development of filarial infection and antifilarial immunity in a cohort of Haitian children. Am J Trop Med Hyg 59: 217-221.
2. Witt C, Ottesen EA, (2001) Lymphatic filariasis: an infection of childhood. Trop Med Int Health 6: 582-606.
3. Fox LM, Furness BW, Haser JK, Brissau J-M, Louis-Charles J, et al. (2005) Ultrasonographic examination of Haitian children with lymphatic filariasis: A longitudinal assessment in the context of antifilarial drug treatment. Am J Trop Med Hyg72: 642-648.
4. Shenoy RK, Suma TK, Kumaraswami V, Rahmah N, Dhananjayan G, et al. (2007) Preliminary findings from a cross-sectional study on lymphatic filariasis in children, in an area of India endemic for Brugia malayi infection. Ann Trop Med Parasitol 101: 205-213.
5. Shenoy RK, Suma TK, Kumaraswami V, Rahmah N, Dhananjayan G, et al. (2009) Antifilarial drugs, in the doses employed in mass drug administrations by the Global Programme to Eliminate Lymphatic Filariasis, reverse lymphatic pathology in children with Brugia malayi infection. Ann Trop Med Parasitol 103: 235-247.
6. Ottesen EA, Hooper PJ, Bradley M, Biswas G, (2008) The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS Negl Trop Dis 2: e317.
7. World Health Organization (2010) Global programme to eliminate lymphatic filariasis: Progress report 2000-2009 and strategic plan 2010-2020.
8. World Health Organization (2011) Global programme to eliminate lymphatic filariasis: progress on mass drug administration 2010. Weekly Epid Record 35: 377-388.
9. Lammie P, Weil G, Rahmah N, Kaliraj P, Steel C, et al. (2004) Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis- a multicenter trial. Filaria J 3: 9.
10. Weil GJ, Ramzy RM, (2007) Diagnostic tools for filariasis elimination programs. Trends Parasitol 23: 78-82.
11. Gass K, Beau de Rochars MVE, Boakye D, Bradley M, Fischer PU, et al. (2012) A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate Bancroftian filariasis. PLoS NTDs 6 (1):: e1479 doi:10.1371/journal.pntd.0001479.
12. Raccurt CP, Lowrie RC Jr, Katz SP, Duverseau YT, (1988) Epidemiology of Wuchereria bancrofti in Leogane, Haiti. Trans R Soc Trop Med Hyg 82: 721-5.
13. Lammie PJ, Hightower AW, Eberhard ML, (1994) The age-specific prevalence of antigenemia in a Wuchereria bancrofti-exposed population. Am J Trop Med Hyg 51: 348-355.
14. Addiss DG, Beach MJ, Streit TG, Lutwick S, LeConte FH, et al. (1997) Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children. Lancet 350: 480-484.
15. Eberhard ML, Lammie PJ, (1991) Filariasis. Laboratory diagnosis of filariasis. Clin Lab Med 11: 977-1010.
16. Burbelo PD, Leahy HP, Iadarola MJ, Nutman TB, (2009) A Four-Antigen Mixture for Rapid Assessment of Onchocerca volvulus Infection. PLoS Negl Trop Dis 3: e438.
17. Kubofcik J, Fink DL, Nutman TB, Identification of Wb123 as an early and specific marker of Wuchereria bancrofti infection. PLoS Negl Trop Dis In press.
18. Gregory WF, Atmadja AK, Allen JE, Maizels RM, (2000) The abundant larval transcript-1 and-2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis. Inf Immun 68: 4174-4179.
19. Krushna NS, Shiny C, Dharanya S, Sindhu A, Aishwarya S, et al. (2009) Immunolocalization and serum antibody responses to Brugia malayi pepsin inhibitor homolog (Bm-33). Microbiol Immunol 53: 173-83.
20. Moss DM, Priest JW, Boyd A, Weinkopff T, Kucerova Z, et al. (2011) Multiplex bead assay on sera from Haitian children enrolled in a drug study for the treatment of lymphatic filariasis. Am J Trop Med Hyg 85: 229-237.
21. Punkosdy GA, Dennis VA, Lasater BL, Tzertinis G, Foster J, et al. (2001) Detection of serum IgG antibodies specific for Wolbachia surface protein (WSP) in rhesus monkeys infected with Brugia malayi. J Inf Dis 184: 385-389.
22. Chandrashekar R, Curtis KC, Ramzy RM, Liftis F, Li BW, et al. (1994) Molecular cloning of Brugia malayi antigens for diagnosis of lymphatic filariasis. Mol Biochem Parasitol 64: 261-71.
23. Ramzy RM, El Setouhy M, Helmy H, Ahmed ES, Abd Elaziz KM, et al. (2006) Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 367: 992-9.
24. Priest JW, Moss DM, Visvesvara GS, Jones CC, Li A, et al. (2010) Multiplex assay detection of immunoglobulin G antibodies that recognize Giardia intestinalis and Cryptosporidium parvum antigens. Clin Vaccine Immunol 11: 1695-707.
25. Waterboer T, Sehr P, Pawlite M, (2006) Suppression of non-specific binding in serological Luminex assays. J Immunol Methods 309: 200-204.
26. Lilley B, Lammie P, Dickerson J, Eberhard ML, (1997) An increase in hookworm infection is temporally associated with ecologic change. Emerging Inf Dis 3: 391-393.
27. World Health Organization (2011) Global programme to eliminate lymphatic filariasis: Monitoring and epidemiological assessment of mass drug administration.
28. Mejia JS, Nkenfou C, Southworth MW, Perler FB, Carlow CK, (1994) Expression of an Onchocerca volvulus Ov 33 homologue in Dirofilaria immitis: potential in immunodiagnosis of heartworm infection. Parasite Immunol 16: 297-303.
29. Frank GR, Mondesire RR, Brandt KS, Wisnewski N, (1998) Antibody to the Dirofilaria immitis aspartyl protease inhibitor homologue is a diagnostic marker for feline heartworm infections. J Parasitol 84: 1231-1236.
30. Corran P, Coleman P, Riley E, Drakeley C, (2007) Serology: a robust indicator of malaria transmission intensity? Trends Parasitol 12: 575-82.
31. Lammie PJ, Hitch WL, Walker EM, Hightower AW, Eberhard ML, (1991) Maternal infection as a risk factor for infection in offspring. Lancet 337: 1005-1006.
32. Beach MJ, Streit TG, Addiss DG, Prospere R, Roberts JM, et al. (1999) Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian school children. Am J Trop Med Hyg 60: 479-486.
33. Huppatz C, Durrheim D, Lammie P, Kelly P, Melrose W, (2007) Eliminating lymphatic filariasis - the surveillance challenge. Trop Med Int Health 13: 292-294.
34. Steel C, Kubofcik J, Ottesen EA, Nutman TB, Antibody to the filarial antigen Wb123 is a marker of reduced transmission and decreased exposure in children born following community wide diethylcarbamazine treatment/. PLoS Negl Trop Dis In press.